Investing Ideas
/
Australian Pharmaceuticals & Biotech Large Cap High Growth Potential

Australian Pharmaceuticals & Biotech Large Cap High Growth Potential

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.

1 companies

CSL

Market Cap: AU$50.0b

CSL Limited, Avustralya, Amerika Birleşik Devletleri, Almanya, Birleşik Krallık, İsviçre, Çin, Hong Kong ve uluslararası alanda biyofarmasötik ve aşı araştırmakta, geliştirmekte, üretmekte, pazarlamakta ve dağıtmaktadır.

CSL

AU$102.95

11.6%

-57.3%